Actelion (Actelion) Days Sales Outstanding : 61.85 (As of Mar. 2017)

View and export this data going back to . Start your Free Trial

What is Actelion Days Sales Outstanding?

Actelion's average Accounts Receivable for the three months ended in Mar. 2017 was $437 Mil. Actelion's Revenue for the three months ended in Mar. 2017 was $645 Mil. Hence, Actelion's Days Sales Outstanding for the three months ended in Mar. 2017 was 61.85.

The historical rank and industry rank for Actelion's Days Sales Outstanding or its related term are showing as below:

ALIOF's Days Sales Outstanding is not ranked ^*
in the Biotechnology industry.
Industry Median: 72.245
* Ranked among companies with meaningful Days Sales Outstanding only.

Actelion's Days Sales Outstanding declined from Mar. 2016 (65.20) to Mar. 2017 (61.85).

Actelion Days Sales Outstanding Historical Data

The historical data trend for Actelion's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actelion Days Sales Outstanding Chart

Actelion Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Days Sales Outstanding

Get a 7-Day Free Trial

99.51

82.40

78.62

74.57

66.69

Actelion Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Days Sales Outstanding	Get a 7-Day Free Trial															65.20	-	-	64.90	61.85

Competitive Comparison of Actelion's Days Sales Outstanding

For the Biotechnology subindustry, Actelion's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Actelion's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Actelion's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Actelion's Days Sales Outstanding falls into.

Actelion Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Actelion's Days Sales Outstanding for the fiscal year that ended in Dec. 2016 is calculated as

	Days Sales Outstanding (A: Dec. 2016 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2015 )	+	Accounts Receivable (A: Dec. 2016 ))	/	count )	/	Revenue (A: Dec. 2016 )	*	Days in Period
=	( (429.327	+	437.383)	/	2 )	/	2371.923	*	365
=	433.355					/	2371.923	*	365
=	66.69

Actelion's Days Sales Outstanding for the quarter that ended in Mar. 2017 is calculated as:

	Days Sales Outstanding (Q: Mar. 2017 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2016 )	+	Accounts Receivable (A: Mar. 2017 ))	/	count )	/	Revenue (A: Mar. 2017 )	*	Days in Period
=	( (437.383	+	0)	/	1 )	/	645.285	*	365 / 4
=	437.383					/	645.285	*	365 / 4
=	61.85

Actelion (OTCPK:ALIOF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Actelion Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Actelion's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Actelion (Actelion) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actelion Ltd (OTCPK:ALIOF) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.actelion.com

Actelion is a Swiss biopharmaceutical firm with several products on the market, largely focused on pulmonary arterial hypertension: Tracleer, Opsumit, Uptravi, Ventavis, and Veletri treat various stages of the disease via different methods of administration. Zavesca is a second-line option for Gaucher disease, and Valchlor treats a rare form of blood cancer. Actelion has created a global commercial infrastructure for its approved orphan drugs and has supplemented its internal pipeline through in-licensing and acquisitions.

Actelion (Actelion) Headlines

From GuruFocus

Eaton Vance Worldwide Health Sciences Fund 4th Quarter Commentary

By Holly LaFon Holly LaFon • 01-24-2017

Eaton Vance Worldwide Health Sciences Fund 4th Quarter Commentary

By Holly LaFon Holly LaFon • 02-14-2017

Jean Hynes Reduces Stake in Actelion

By Kyle Ferguson Kyle Ferguson • 08-03-2016

Actelion Still On Growth Track

By reports.droy reports.droy • 02-18-2015